Cutaneous Manifestations of COVID-19 in Children

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARSâ€CoVâ€2) and the ensuant disease coronavirus disease 2019 (COVIDâ€19), has erupted as global pandemic. Clinical presentation, course and outcome of disease is different in children. Besides, respiratory symptoms, patients of COVID-19 can present with diverse cutaneous manifestations seen in 0.2% to 20% of patients, and 3.4% of children. Common dermatologic findings include pseudochilblain (COVID toes, maculopapular (morbilliform) exanthem, urticaria, vesicular rash, erythema multiforme and Kawasaki disease-like inflammatory multisystemic syndrome. Cutaneous involvement usually occurs concurrently with the systemic symptoms; nonetheless, these can follow or precede the systemic features. Any correlation between COVID-19 severity and cutaneous manifestations remains speculative. These cutaneous changes may guide to early diagnosis and treatment of COVID-19.